Head and Neck Cancer Is Known To Originate In Flat Squamous Cells That Make Up the Skin on the Surface of the Head and Neck

 

Head and Neck Cancer
Head and Neck Cancer

Early detection and treatment are the keys to successful head and neck cancer treatment. Three-quarters of head and neck cancers are detectable during a physical examination. To find the source of the disease, healthcare providers perform a physical exam and order diagnostic tests. During the physical examination, healthcare providers look for any abnormalities in the neck, tongue, throat, or oral cavity. Laboratory tests may also be performed on samples of tissue.

According to Coherent Market Insights the Head and Neck Cancer Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028.

Most types of head and neck cancer originates in flat squamous cells. These cells make up the skin on the surface of the head and neck. Mucosa is the moist tissue in these areas. If cancer is detected in this layer, it is referred to as a carcinoma in situ. If it has spread deeper tissue, it is known as invasive squamous cell carcinoma. Cancers of unknown primary are also rare however, may occur in the head and neck. Head and neck cancer includes many types of throat, larynx, and nose cancer. It may also develop in salivary glands, nose, and sinuses. Treatment options depend on the specific type of head and neck cancer that patients have. Most cancers of the head and neck can be cured if detected early. The most common risk factors are tobacco, alcohol, and the human papillomavirus. 

While the goal of head and neck cancer treatment is to treat the cancer, doctors are also concerned with the quality of life after treatment. While radiation therapy and surgery often result in changes in voice, doctors also focus on the function of the neck and face and helping the patient return to normal activities. This process of rehabilitation is an integral part of the recovery process and the specific goals are determined by the type and extent of the disease. While the surgery will impact a patient's ability to talk, swallow, or chew, these changes will often improve over time. Recently in June 2022, a specialist team of head and neck cancer at the UT Southwestern Medical Center in the U.S. launched a first randomized study of daily adaptive radiation therapy that will use Ethos technology of Varian to treat head and neck cancer in patients.

Comments

Popular posts from this blog

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Organic Milk Has Much Higher Concentration Of Iron, Vitamin E, And Polyunsaturated Fatty Acids Omega-3 And Omega-6 As Compared To Regular Milk